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I. INTRODUCTION
Human cytomegalovirus (CMV) is increasingly recognized as an important human
pathogen (43). This virus produces a series of clinical pictures varying from classic
"Scytomegalic inclusion disease" to intrauterine death, prematurity, congential
defects, infectious mononucleosis, postperfusion syndrome, and interstitial pneu-
monia in patients who have undergone organ transplantation (29, 43). It is likely that
other diseases or syndromes caused by human cytomegalovirus have not yet been
recognized. The observations that human CMV may cause normal human fibroblast
cells to multiply and grow in soft agarose (28) and that human CMV has the ability to
transform hamster-embryo fibroblasts (1) suggest that human CMV might have
oncogenic potency comparable to that of herpes simplex, Epstein-Barr virus (EBV),
and other herpes-group viruses.
Human CMV has been isolated from saliva, urine, blood, human milk, cervical
secretions, various tissue specimens, and even from human semen (30, 43). In con-
genital and postnatal infections, the virus is excreted from saliva and urine for a sus-
tained period and then apparently enters a latent state. Recurrence of excretion of
CMV in pregnancy (31, E. R. Alexander, and our unpublished observations), reacti-
vation of CMV replication in immunosuppressed patients (8), and the presence ofin-
fectious CMV in fresh donor bloods (7) strongly indicate the latency of human CMV
infections as found with other herpes-group viruses.
The peculiar thermal and chemical lability ofhuman CMV, the slow appearance of
cytopathic effects, the slow growth cycle in tissue culture and the remarkable anti-
genic variation, plus the lack of specific heterologous hyperimmune serum present
complicating factors in the diagnosis of human CMV infection. In this communica-
tion we would like to discuss some ofour new approaches for virus detection, as well
as the study of strain differences as approached by nucleic acid hybridization, restric-
tion endonuclease analyses ofthe CMV genome, and antigenic analyses.
II. DETECTION
Detection of cytomegalovirus infection by isolation in tissue culture and immu-
nologic procedures (e.g., neutralization, fluorescent antibody, and platelet-agglutina-
tion tests, complement-fixation, detection of CMV IgM, and immunoperoxidase la-
beling technique have been described previously in several publications and review
articles (3, 6, 14, 16, 17, 22, 27). Here we would like to introduce several new tech-
niques which are applicable to the human cytomegalovirus system.
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(A) Anti-Complement (C'3) Immunofluorescence Test (ACIF)
The ACIF test was recently introduced by Reedman and Klein in the
Epstein-Barr virus (EBV) system for detection of the EBV-specific nuclear antigen
(EBNA) (36); this antigen is difficult or impossible to detect by indirect im-
munofluorescence. The ACIF test is based on the ability of specific antigen and anti-
body reactions to fix complement; with FITC conjugated anti-complement serum,
the location of the fixed complement can be demonstrated. This test has proven to be
more sensitive than the classic direct or indirect immunofluorescence tests (13, 19)
due to its amplifying effect and because it detects both IgM and IgG classes of anti-
body-antigen reactions that fix complement. Anti-viral hyperimmune sera prepared
from cattle and many species of birds cannot be used in this test because these sera
are inactive in fixing complement.
In brief, frozen sections or exfoliated cells were first fixed with ice-chilled acetone. Anti-CMV hyperim-
mune serum prepared in guinea pigs (22) was mixed with complement and applied to the samples. These
were incubated in a moist CO2 incubator for 40 min. We used human serum without EBV, herpes simplex,
CMV, and varicella-zoster CF antibodies as the complement source. After extensive washing, the FITC-
conjugated anti-human C3 (#IC/f,A globulin, Hyland) together with rhodamine counterstain were applied
to the sample and incubated for another 45 min. Essential to correct interpretation ofthis test is a control
specimen to which CMV antiserum is not applied. This control will detect the presence ofany cells which
process complement receptor sites that are able to fix complement and give a false positive result (e.g., B
lymphocytes).
Figure 1 shows the detection ofCMV antigens by the ACIF test. The specimen is a
frozen section of kidney from a congenitally CMV-infected infant. The location of
CMV antigens is mainly in cuboidal epithelial cells ofcollecting tubules.
.... ..._.............
FIG. 1. Detection of human CMV in the kidney by anti-complement immunofluorescence (ACIF). The
frozen section of kidney was fixed with cold acetone for 10 min and rinsed with phosphate buffer three
times. Diluted heat-inactivated anti-CMV serum (strain AD-169) together with fresh human complement
was applied. The reaction was carried out at 37' C in a moist CO, incubator for 45 min. The slide was then
washed extensively. Goat antiserum to human C'3 (FITC conjugated to f#IC/f3IA globulin from Hyland,
Calif.) was then applied for detection of specific complement fixation. The location of the CMV antigen
was mainly in cuboidal epithelial cells of the collecting tubules (magnification about 1000 x).
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The degree of specificity and the level of background fluorescence depend strongly
on the sources of complement and conjugated anti-C'3 serum. Unsatisfactory com-
mercial products are always encountered. Fractionation and removal of nonspecific
contaminants by column chromatography seem to be essential for elimination of
background and nonspecific reactions (27).
As shown in Fig. 7, there is heterogeneity of CMV complement fixing antigen (or
antigens) among various CMV strains. Some strains have no crossing-over of CF
antigen. In view of this important finding we have pooled eight strains of hyperim-
mune sera, prepared in the guinea pig against purified viruses, as multispecific sera
which should cover a broad spectrum of human CMV for clinical diagnostic pur-
poses.
(B) Detection ofHuman CMV Genome by Nucleic Acid Hybridization Techniques
As with herpes simplex virus, human CMV has a genome size around 108 daltons.
A genome this size is sufficient to code for 200-300 virus-specific proteins of which
only 15-20% may be structural proteins associated with purified virions (20). Hy-
perimmune sera against purified virions may not be able to detect the virus in
unexpressed or latent states similar to the situation found with Raji cells that carry
EBV DNA (32, 36). As detected by DNA-DNA reassociation kinetics analysis, we
have found that all human CMV strains tested to date share at least 80% homology
in DNA sequence (Fig. 5). We performed nucleic acid hybridization in parallel with
tissue culture isolation and immunologic methods for detection ofCMV.
Three kinds of nucleic acid hybridization techniques are available for human
cytomegaloviruses: (i) complementary RNA (cRNA)-DNA hybridization on
nitrocellulose membranes; (ii) in situ cRNA-DNA cytohybridization; and (iii)
DNA-DNA reassociation kinetics analysis. These techniques require highly specific
radioactively labeled viral cRNA or in vitro labeled viral DNA as probes. In order to
prepare the viral DNA to serve as template for the synthesis of virus-specific cRNA
or in vitro labeled viral DNA, we use only purified extracellular virus. The virus
(strain AD-169) was concentrated from the clarified supernatant fluids of infected
cells and purified through sucrose and preformed CsCl gradient centrifugation as
described previously (20). The viral DNA was released from the purified virus by
treating with sodium deodecyl sulfate (SDS) and pronase. The DNA was then puri-
fied by sedimentation through 10-30% sucrose gradients and by two cycles of
isopycnic centrifugation in cesium chloride (20).
(C) Synthesis ofHuman CMV-Specific 3H (or 1251) cRNA
E. coli DNA-dependent RNA polymerase (transcriptase) is used for synthesis of
viral specific cRNA with purified viral DNA as template. This transcriptase from E.
coli (strain Q13, RNase-) is prepared according to the method of Burgess (5); the
activity ofthe enzyme is around 200 units/ml and 400 units/mg ofprotein.
The CMV template DNA (2 ytg in 0.12 ml), E. coli transcriptase, 6 units in 30ml, and 0.1 ml of reaction
mixture containing 0.1 M Tris-HCl, pH 7.9, 0.025 M MgCl2, 0.25 mM EDTA, 0.25 mM dithiotheitol,
0.375 M KC1, 1.25 mg of bovine serum albumin/ml, 0.375 mM of ATP, GTP, and CTP, and 0.5 mCi of
[3H]UTP (30 Ci/mM) were mixed and kept at 37'C for 2 hr. After reaction the DNA was digested with
pancreatic DNase (RNase-free, Worthington) at a concentration of 40 ,g/ml for 30 min; and SDS was
added to stop the reaction. The mixture was chromatographed through a Sephadex G-50 column in 0.1 x
SSC and 0.01% SDS buffer. The first peak of radioactivity and absorbancy (A260) was collected, extracted
with phenol or chloroform three times, and dialyzed against three changes of0.1 x SSC with 0.01% SDS
at 4' C for 24 hr. The efficiency of incorporation of [3H]UTP into acid-precipitable RNA was about 6% of
31HUANG ET AL.
the total input. Complementary RNA with a specific activity between 8 x 103 and I x 107 cpm/gg was ob-
tained (20).
For synthesis of['25I] cRNA, 5-[(251]Iodo-CTP and cold UTP were used to replace CTP and [3HJUTP
in the above reaction mixture. The details of the synthesis of 5-['25I]Iodo-CTP have been described pre-
viously (38).
(D) Complementary RNA-DNA Hybridization on
Nitrocellulose Membrane Filters
Total DNA was extracted by pronase-SDS from cells or tissues thought to harbor
viral nucleic acid (20). The DNA was denatured with alkali and immobilized on
nitrocellulose membrane filters (Schleicher and Schuell), and radioisotopically la-
beled CMV cRNA was applied. The hybridization was carried out by the method of
Gillespie and Spiegelman (12) and as described before (20) at 66°C in 6 x SSC for 16
to 20 hr. The filters were then extensively washed and treated with pancreatic RNase
to remove nonhybridized cRNA. Radioactivity above the nonspecific background
level indicates that a specific hybridization of the radioactive cRNA to comple-
mentary DNA sequences in the extracted DNA has occurred, and viral DNA must
be present in the tissue. Not only can viral DNA, whether encapsidated or nonencap-
sidated, be detected, but also a quantitative estimation of the number of viral
genomes can be made.
Figure 2 shows the reconstruction curve which provides the basis for the viral
genome calculations. This curve was constructed based on the amount of radioactive
CMV cRNA hybridized to a graded amount of CMV DNA in the presence of 50 ,ug
of HEp-2 or calf-thymus DNA. If the molecular weight of CMV DNA and diploid
human cell DNA are 108 and 4 x 1012 (20), respectively, then 0.1 tg ofCMV DNA in
50,ug of human tissue DNA is equivalent to 80 CMV genomes per cell. The counts of
cRNA hybridized to 0.1 ,ug ofCMV DNA in the presence of 50,ug of HEp-2 DNA is
3882 cpm which is equal to 48 cpm/genome/cell. By this calibration we should
readily detect as few as two genome equivalents per cell. Detection of fewer genome
equivalents would be unreliable because of the usual background of nonspecific
100
L 10 -
u 1
Q001 0.01 0.1 1
CMV DNA(Al9)
FIG. 2. Membrane hybridization of CMV [3H]cRNA to CMV DNA. Graded amounts of CMV DNA
(0.001-1 sg) were mixed with 50pg of HEp-2 DNA (in 0.1 x SSC) and denatured in 0.5 N NaOH for 2-3
hr at 37°C. The DNA solution was neutralized with 1.1 N HCl in 0.2 M Tris, adjusted to 6 x SSC, and
immobilized on nitrocellulose membrane filters. The input cRNA for each filter was 1.5 x 105 cpm (sp act
is about 107 cpm/ug). The amount ofDNA retained on the filter, determined by a diphenylamine test after
hybridization, remained constant. The background hybridized counts for 50,g of HEp-2 DNA (130 cpm)
were subtracted from each value.
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hybridization. In this case the more sensitive DNA-DNA reassociation kinetics
analysis should be applied if the quantity of sample DNA is sufficient.
(E) Complementary RNA -DNA Cytohybridization in situ
A potentially useful technique for viral diagnostic work is known as cRNA-DNA
cytohybridization in situ. This test is derived and modified from classic cRNA-DNA
membrane hybridization. However, in this method the cellular DNA is not extracted;
rather, the hybridization of radioactive labeled cRNA to DNA is carried out directly
in fixed cells or specimens. The site at which the specific hybridization occurs can be
localized and detected by autoradiography.
This method is adapted from that of Gall and Pardue (1 1) and has been successfully used for the human
cytomegalovirus system (20, 34).
Frozen sections (6 to 10 M in thickness) or exfoliated cells, virus-infected tissue-culture cells, or other
specimens were applied to the slide and fixed with freshly prepared ice-chilled fixative (ethanol, 3 parts,
and acetic acid,
1 part) for 10 to 15 min. After dipping in 95% alcohol (ETOH) and absolute alcohol
(ETOH) to remove the residual acetic acid, the slides were then dipped into 0.4% agarose at 60° C and air
dried to form a thin agarose layer on the slide to prevent detachment of cells.
The denaturation of DNA was carried out by alkalinizing the specimens in 0.07 N to 0.1 N NaOH for 3
min. The slides were then washed extensively with 70% alcohol (ETOH) and absolute alcohol (ETOH) and
air dried.
One-tenth of a milliliter of CMV 3H (or 1251) cRNA (3 x105 cpm/0.1 ml with1 mg yeast RNA, 0.1%
SDS, and 6 x SSC) was applied to each slide and covered with a coverslip to prevent evaporation. The
specific activity of the [3H]RNA was about1 x107 cpm/gg and of the ['25I]RNA about 4 x107 cpm/4g
(38). The hybridization was carried out in a moist chamber at 70° C for 20 hr. The slides were rinsed with
2 x SSC four times and treated with 40,4g/ml pancreatic RNase for 30 min at 37°C. After extensive
washing again with 2 x SSC, the slides were sequentially dehydrated with 70%, 95%, and absolute alcohol
and dried.
Kodak Nuclear Track NTB 2 was used for autoradiography. The exposure time for tritiated labeled ma-
terial ranges from 4 weeks to 2 months, but for 1251 material the time is overnight to1 week; the time de-
pends mainly on the specific radioactivity of viral cRNA and also on the viral DNA content of the cells.
Recently we have been able to shorten the exposure time of 3H-labeled material from 4 weeks to1 or 2
days by dipping the emulsion-covered slide (after complete drying) in liquid scintillation fluid-dioxane and
PPO(1% w/v), and POPOP (0.02%). The detailed procedure for development and Giemsa staining was
described previously (34).
Figure 3 shows an example of cRNA-DNA cytohybridization in situ with CMV
[3H]cRNA applied to kidney tissue (in collaboration with Dr. G. Nankervis). The
tissue was from autopsied kidney of a congenitally infected infant with CMV infec-
tion (as described above in ACIF test). This photograph does not represent the incor-
poration of [3H] thymidine in the DNA, but rather the hybridization of CMV
[3H]cRNA to the viral DNA in the cells. The gains which deposit heavily in cuboidal
epithelial cells in the collection tubules represent the localization of viral DNA. As
shown in Fig. 1, CMV viral structural antigen was also detected in these cells by the
ACIF test.
We have used this technique to detect CMV in leukocytes and in human semen as
well as in various autopsied specimens. This technique is quite reliable; the viral
genome can be detected whether or not infectious virus is present. There is no need
to use tissue culture. As mentioned above, one of the great advantages of this tech-
nique is that it permits not only the detection of viral genome but also its location as
to the cell type in a mixed cell population and its intracellular location. However one
does need virus-specific radioactive cRNA for use as the specific probe. This specific
probe is not yet available commercially, and it is relatively expensive to prepare as
compared to those agents used in the immunofluorescence tests.
RNA-DNA cytohybridization is not as sensitive as cRNA-DNA membrane
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FIG. 3. Complementary RNA-DNA cytohybridization in situ with CMV [3H]cRNA applied to kidney.
A tissue block from the kidney ofa congenitally CMV-infected infant was embedded in Ames O.C.T. com-
pound. The tissue was sliced into sections 6 um thick, transferred to slides, and fixed with freshly prepared
fixative. After dehydration the section was exposed to 0.07 N NaOH for 3 min and dehydrated with 70%
and 95% ethyl alcohol. The cytohybridization was carried out as described in the text.
hybridization because in the fomer method fewer cells are examined, whereas in the
latter method the total DNA is extracted from a number of cells for hybridization
and testing. But if most of the viral genomic material is confined to only a few cells,
then the cytohybridization is considered to be relatively sensitive.
(F) DNA-DNA Reassociation Kinetics Analysis
Precise quantitation of viral genome in the tissue can be achieved by DNA-DNA
reassociation kinetics analysis (4, 20, 25, 33, 44). This technique can detect as little as
0.2 viral genome per cell when 2 mg of total cellular DNA is used. This technique
also can be used for studying genetic relatedness and interstrain homology (23). This
analysis is based on the principle that under fixed conditions the kinetics ofreassocia-
tion of a pair of complementary DNA strands that have been denatured and allowed
to reanneal are dependent on the complexity ofthe DNA and the collision frequency
of the complementary DNA strands. Therefore the period for the reannealing of a
particular DNA should be inversely proportional to its concentration (4, 44). If we
are examining a cellular DNA preparation obtained from a tissue or cell specimen
with cytomegalovirus infection, the addition of this DNA into the reassociation mix-
ture, which contains a constant amount of radioactive viral DNA probe, increases
the total concentration of CMV DNA in the system. Therefore, the reannealing of
the radioactive DNA probe is accelerated by the admixed DNA. From the degree of
acceleration of reannealing, we can quantitate precisely the amount of viral DNA in
the test specimen.
Pure viral DNA with high specific radioactivity is essential for this analysis. In
view ofthe difficulty ofobtaining viral DNA with high specific radioactivity by in vivo
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labeling, we applied nick-translation with Kornberg's enzyme to label CMV DNA in
vitro. The purified CMV DNA was first randomly nicked with a low concentration of
pancreatic DNase I and then subjected to repair synthesis with DNA polymerase I.
Through combined 3' polymerization and 5' exonuclease digestion, the cold TMP
residues in the CMV DNA are gradually replaced by radioactive TMP. This method
essentially follows that used to label Epstein-Barr virus DNA (33) and has been
described in detail previously (20, 23). The specific radioactivity of in vitro labeled
DNA obtained ranged from 1.6 to 3 x 106 cpm/tig.
The in vitro tritium-labeled CMV DNA and unlabeled test-cell DNA were fragmented by ultrasonic vi-
brations to about 5S as determined by preparative ultracentrifugation. The procedure for DNA-DNA
reassociation followed the method of Kohne and Britten (25) modified as described previously (20, 23). In
brief, 0.01 gg of probe [3H]CMV DNA (about 1.6- 3 x 104 cpm) and unlabeled test-sample DNA in 0.01
M Tris-HCl, pH 7.4, and 0.0025 M EDTA were denatured at 100°C for 15 min. After rapidly chilling in
ice, the salt concentration was adjusted to 0.9 M NaCl, and the DNA was then allowed to reanneal at
66°C. The proportion of reassociated DNA was determined either by hydroxyapatite chromatography
(25) or S, enzyme differential digestion (23).
As part of a study of the genetic relatedness among viruses in the herpes group we
have shown the lack of detectable nucleic acid homology between a strain of human
CMV (AD-169) and herpes simplex type 1 and type 2, EBV, murine CMV, and
simian CMV by DNA-DNA reassociation kinetics analysis (23). Our next effort was
to demonstrate by the same technique the degree of relatedness or difference
between strains of human CMV. Figure 4 shows the results of an experiment in
which in vitro labeled [3H]CMV DNA (strain AD-169) was used in comparison with
some unlabeled viral DNAs purified from different strains ofhuman cytomegalovirus
(Davis, Esp, and TW-087) and from a virus (Colburn) isolated from human brain; the
last virus was isolated from a child with encephalitis; in tissue culture the virus re-
sembled CMV. The results show that the DNAs from strains Davis, TW-087, and
Esp do accelerate the reassociation of [3H]AD-169 DNA probe with kinetics that in-
dicate more than 80% nuclei acid homology among these human CMV strains. Col-
burn virus and its DNA do no resemble human CMV; the virus was found to be re-
lated to monkey CMV (manuscript in preparation).
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FIG. 4. Reassociation kinetics analysis oftritiated AD-169 CMV DNA with the DNA ofColburn virus
and various human CMV isolates.
Sonically disrupted 3H-labeled AD-169 DNA, 0.01 ltg (2.7 x 104 cpm), 20gg ofcalf-thymus DNA, and
2 ,ug ofunlabeled viral DNA were mixed and heat denatured in the presence of0.01 M Tris-HCl (pH 7.4)
and 0.0025 M EDTA. The salt concentration was then adjusted to 0.9 M NaCl. The hybridization was car-
ried out at 66°C, and the fraction of reassociated [3H]DNA was analyzed by S, enzyme differential diges-
tion as described above. Calf-thymus DNA control (0); Colburn DNA (*); Davis DNA (A); TW-087 DNA
(-); Esp DNA (-); and homologous AD-169 DNX (X).
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III. VIRUS STRAIN VARIATION
Early in 1960 Weller et al. reported that human CMV was not an antigenically
homogeneous group (41). Since then, more evidence indicates that human CMV has
considerable antigenic diversity (42, 43). With the use of sera from congenitally
CMV-infected infants, Weller et al. (41) examined three culture-adapted strains
from congenitally infected infants and Rowe's AD-169 virus isolated from adenoid
tissue by kinetics of neutralization and concluded that strains Davis and AD-169
were sufficiently distinct to be classified as type 1 and type 2. Strains Esp and Kerr
were tentatively placed in a third antigenic group that exhibited some cross-reactivity
with the type 1 Davis strain. In 1969 Krech and Jung (26) prepared antisera to human
CMV in the guinea pig and reported that sera neutralizing the Davis strain lack
activity against the ESP strain.
It has been 15 years since Weller's preliminary serological classification with
patients' sera: No further attempt has been made to assign the genetic or antigenic
relatedness among strains isolated from different organs or from different diseases.
From the therapeutic or preventive point of view, it is urgent to have a comprehen-
sive classification of human CMV based on antigenicity and nucleic acid homology.
The selection of strains suitable for vaccination, for passive immunization, and for
diagnosis will be completely based on this information. Motivated by these considera-
tions, we have now propagated and purified 12 strains of human CMV from various
sources in relatively large amounts to produce hyperimmune sera of high titer in
heterologous species for antigenic study and to prepare purified viral DNAs for de-
termination ofnucleic acid homology.
Viral nucleic acid homology studies by DNA-DNA reassociation kinetics analysis
and by restriction enzyme analysis combined with the immunologic data are being
used to define strain variations and to approach the questions posed by the variety of
pathogenic manifestations of CMV infection. Some of our preliminary observations
are as follows.
(A) Cytomegalovirus Strains and Origin
AD-169, isolated from adenoid tissue by W. Rowe, Bethesda, Md., passage
285-289 (37,41).
Davis, isolated from liver, T. Weller, Boston, Mass., passage 65-68 (41).
Kerr, from urine, U.S. Naval Hospital, Chelsea, Mass., passage 23-28 (41).
Esp, from urine, Babies Hospital, New York, passage 43-48 (41).
C-87, isolated from kidney, M. Benyesh-Melnick, Houston, Tex., passage 58-63
(2).
NC496, liver biopsy, Chapel Hill, N.C., passage 3-5.
Town, congenital infection, S. Plotkin, Philadelphia, Pa., passage 29-35 (10).
UW-1, urine, CMV inclusion disease, B. Wentworth, Seattle, Wash., passage
33-35 (6).
RCH234, Australian strain, from B. Wentworth, Seattle, Wash.
TW-087, from cervix, E.-S. Huang, Taipei, Taiwan, passage 20-24.
Clegg, from human semen, Chapel Hill, N.C.; specimen from D. Lang.
Colburn, isolated from brain tissue taken from a 6-yr-old boy suffering from an
encephalopathy, obtained from C. Alford, Birmingham, Ala., passage 80-85.
(B) Interstrain NucleiAcidHomology
DNA-DNA reassociation kinetics analysis of3H-labeled AD-169 CMV DNA with
unlabeled DNA of various CMV strains (Fig. 5) shows that all the human CMV
36DETECTION AND ANALYSIS OF CMV
0 20 YNV
4 1
a26(I _ o control I
060- x AD169
S C-87 1 .uw-l V4
80 v Town ADav's A
1 10 100
INCUBATION TIME (hr)
FIG. 5. Reassociation-kinetics analysis of tritiated AD-169 DNA with DNA of various human CMV
strains. Sonicated [3HJAD-169 DNA, 0.01 Mg (2.7 x 104 cpm), 20 Mg of calf-thymus DNA, and 2 ,ug of
unlabeled virus DNA were mixed and denatured. The experiment was carried out as described in Fig. 4.
strains examined (Colburn is considered here not to be a human CMV strain) share
at least 80% homology with AD-169 DNA. The degree of homology existing among
human CMV strains is greater than that between herpes simplex type 1 and type 2,
which is about 50% (24). Clegg and TW-087 are genital tract strains; both DNAs ac-
celerated the probe [3H]AD-169 DNA reassociation to the same extent as did the
homologous control AD-169 DNA. These results indicate that human CMV strains
do have major common nucleic acid sequences. However heterogeneity of nucleotide
sequence does exist.
(C) RestrictionEnzymeAnalysisofHumanCMVDNA
Restriction endonucleases EcoR-R-1 purified from E. coli strain Ry13 (15), and
Hind III (40) purified from Haemophilus influenzae serotype d were used in this
study. All virus DNAs were labeled with 32P in infected cells, and the DNA was puri-
fied from a purified extracellular virus preparation as described previously (20).
Enzyme-digested virus DNA fragments were separated in a 1 % agarose slab-gel
electrophoresis system. After electrophoresis the gel was vacuum-dried onto filter
paper and exposed to X-ray film. Details of digestion and electrophoresis are
described elsewhere (Kilpatrick, Huang, and Pagano,J. Virology, in press).
EcoR- R-1 or Hind III digestion ofDNA from several CMV isolates yields distinct
fragments for each isolate (Figs. 6A and B). Coelectrophoresis of EcoR*R-1 or Hind
III digests shows considerable matching of comigrating fragments among several
human isolates; however, no two isolates have identical fragment-migration patterns.
The degree of matching among human isolates appears to be greater for products of
EcoR R-l digestion than for products of Hind III among the same strains. This
would make the Hind III digests a more sensitive comparison of isolates than the
EcoR* R-1 digests. However, for purposes ofdistinguishing between human and non-
human CMV isolates, it is expected that both enzyme products will be equally useful.
Comparison of EcoR*R-1 or Hind III digests ofhuman CMV isolates with digests of
a simian isolate (GR-2757) shows little if any matching of fragments. The Colburn
isolate obtained from human brain shows significant matching or comigration offrag-
ments with simian virus GR-2757. This finding appears to be supported by
DNA-DNA reassociation kinetics analysis as shown above. It is not known to what
degree these digests reflect the laboratory passage history ofthese isolates.
Herpes simplex type 1 viruses have EcoR- RI and Hind III digestion products dis-
tinct from the type 2 viruses; there are rare comigrating fragments (18, 39). HSV
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FIG. 6. Comparison and analysis of various cytomegalovirus strains by cleavage of their DNA with
restriction endonucleases EcoR- R-l and Hind III. CMV DNA labeled with 32P and purified as described
in the text was dissolved in TBS (0.05 M Tris-HCI, pH 7.4, and 0.15 M NaCl) and digested with either
enzyme in the presence of 10 mM MgCl2 and 5 mM f-mercaptoethanol for 24 hr at 37°C. All samples
were electrophoresed on a 1% agarose slab gel in I E buffer (21) until the tracking dye (bromphenol blue)
migrated to the bottom of the gel. The gels were dried and exposed to X-ray film as described (21). KOS, a
strain of herpes simplex virus, was used as a marker and a control for digestion condition. Panel (A)
EcoR*R-1 digests; (B) Hind III digests. KOS in both panels (A and B) was digested and generated with
EcoR-R-1 enzyme.
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types I and 2 also have only about 48% nucleic acid homology (24). However, the
strains of CMV, as discussed above, show at least 80% nucleic acid homology.
EcoR-R-l or Hind III digestion of the DNAs reflect his homology, and although
there are important differences, no obvious distinction into groups or classes of
isolates has been found. A more detailed discussion of these digestion products will
be found elsewhere (Kilpatrick, Huang, and Pagano, J. Virology, in press).
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FIG. 7. Complement-fixation antibody titer of sera from guinea pig hyperimmunized to human CMV:
titration against homologous and heterologous antigens. Antibody dilutions in microtiter plates containing
2 units of antigen and 2 units of complement were incubated overnight at 4° C. The method employed and
preparation of CF antigen was described previously (22). Antigen "C" represents the host-cell antigen
(WI-38 human fibroblast) control.
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(D) A ntigenic Heterogeneity among Human CMVStrains
Antisera were prepared in guinea pigs with strains of purified human CMV as
published (22). The heterogeneity of the CMV strains was determined by comple-
ment fixation; immunofluorescent, indirect hemagglutination, and neutralization
tests are in progress. From the CF data as shown in Fig. 7, it is clear that great
heterogeneity of CF antigens do exist among those human CMV strains tested.
There is no cross-reaction between C-87 and Clegg or between C-87 and Kerr,
whereas there is one-way cross-reaction between several ofthe strains, e.g., C-87 and
RCH, C-87 and TW-087, Davis and Clegg, Davis and Rowe, Davis and TW-087, Esp
and TW-087, Clegg and Kerr.
Anti-NC-496 serum has a CF titer pattern similar to that of anti-RCH serum.
Besides this, no identical pair can be found. The data from Fig. 7 suggest that it is
difficult to classify human CMV strains into type or group according to complement-
fixation pattern. Due to lack of immunologic cross-over between certain CMV
strains, it is important to use multivalent hyperimmune sera when the CF test is em-
ployed for viral diagnostic purposes.
IV. DISCUSSION AND CONCLUSION
We approach the detection of human cytomegalovirus infection and the discrimi-
nation of strain differences by both nucleic acid hybridization techniques and immu-
nological analyses. The reasons for applying nucleic acid analyses as a tool in detec-
tion and classification are first that human CMV antigen has such a large diversity
that detection or analysis of the structural antigens alone cannot delineate all viral
genetic information, and second that some viral information may not be expressed as
a structural antigen.
As shown in the DNA-DNA reassociation kinetics analysis, human cyto-
megalovirus isolates share at least 80% of nucleic acid sequences in common. The
difference in nucleotide sequence among these human CMV strains is obviously less
than the difference between herpes simplex virus type 1 and type 2 (18, 24). Restric-
tion endonuclease cleavage patterns of these human CMV strains show the
heterogeneity of the genome structure, but these strains do share common comigrat-
ing fragments. These comigrating fragments observed after EcoR R-l or Hind III
cleavage and gel electrophoresis might be constant regions responsible for common
CMV biological characteristics and possibly could serve as markers for virus identi-
fication purposes.
Preliminary study of the genital strains isolated from semen and cervix, Clegg and
TW-087, do not disclose any great distinction from other human CMV isolates by
reassociation kinetics analysis and restriction endonuclease analysis (manuscript in
preparation) as exists between herpes simplex virus type 1 and type 2 (18, 24, 35).
Before final conclusions can be made, further investigation is necessary.
In analyses of restriction enzyme cleavage and electrophoresis patterns of Town
strain (10) DNA, we do not find any significant variation between passage 30 and 36.
With a given restriction enzyme the resultant cleavage pattern is very consistent with
low multiplicity infections (MOI is about 1 PFU). Any major change in the cleavage
sites might occur when the viruses are first subjected to the tissue culture cultivation
system. To resolve this question, we intend to examine virus collected directly from
urine having a high virus titer.
Although we do not yet have complete information from neutralization kinetics
analyses and immunofluorescence tests, the data obtained from complement fixation
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tests with hyperimmune sera prepared from purified virus show that great
heterogeneity of CF antigen exists among various human CMV isolates. There is no
crossing-over between several strains.
Combining the data obtained from nucleic acid hybridization, restriction enzyme
analysis, and complement fixation, we still find it quite difficult to classify human
CMV isolates into types or subgroups; each isolate can serve as a type. As Weller
stated, this is an ubiquitous agent, pantropic in character with great antigenic and
genetic diversity.
As shown above, the nucleic acid hybridization techniques are very useful for de-
tection of human cytomegalovirus. Due to their expense and the complicated tech-
niques, these procedures may be only suitable for research purposes at the present
moment. They are of great value in providing fundamental information on the
pathobiology ofCMV infection.
V. SUMMARY
Detection and localization of human cytomegalovirus antigens and viral genomes
was accomplished by nucleic acid hybridization techniques (cRNA-DNA membrane
hybridization, cRNA-DNA cytohybridization in situ, and DNA-DNA reassociation
kinetics analysis) and anti-complement immunofluorescence tests. Study of inter-
strain genetic relatedness by DNA-DNA reassociation kinetics analysis shows that
the human CMV isolates examined share at least 80% homology with AD-169 DNA.
Restriction endonuclease cleavage of DNA from several CMV isolates shows
considerable comigration offragments. However, no two isolates have identical frag-
ment-migration patterns. The heterogeneity ofthe antigens of the CMV isolates was
also demonstrated by complement fixation with antisera prepared in guinea pigs
against purified preparations of human CMV isolates. Thus far it is difficult to
classify human CMV strains into types or groups, although important differences
seem to exist.
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